BCL2 and leukemia: In the cells cultured in vitro, the synergistic use of HHT and BTZ enhanced the cytotoxicity of BTZ against K562 leukemia cells, reduced the expression of the anti-apoptotic proteins Bcl-2 and Mcl-1, while enhancing the expression of the pro-apoptotic protein Bax (15).